ALXO logo

ALX Oncology Holdings (ALXO)

Profile

Full Name

ALX Oncology Holdings Inc.

Ticker Symbol

ALXO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 17, 2020

Indexes

Not included

Website

http://www.alxoncology.com

Employees

80

Key Details

Price

$0.50(+2.31%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.58(+31.02% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.50
ALXO price is $0.50

30-Day Relative Volume

0.34
ALXO 30-day relative volume is 0.34

Price Performance

Price Most recent change

+2.31%
ALXO price was up +2.31% on Apr 14, 2025

Price YTD change

-69.98%
ALXO price is down -69.98% since January 1st

Price 1-year change

-96.15%
ALXO price is down -96.15% year-on-year

Price 3-year change

-96.87%
ALXO price is down -96.87% over the past 3 years

Price Range

Price All-time high

$117.45
ALXO price is currently -99.57% below its historical high of $117.45

Price 3-year low

$0.46
ALXO price is currently +8.98% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$26.76M
ALXO market capitalization is $26.76 million

Market cap 3-year change

-95.89%
ALXO market capitalization is down -95.89% over the past 3 years

Market cap All-time high

$4.17B
ALXO market capitalization is currently -99.36% below its historical high of $4.17 billion

Market cap sector rank

30.16%
ALXO market capitalization is higher than 30.16% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+6.18%
ALXO shares outstanding is up +6.18% year-on-year

Shares Outstanding 3-Year Change

+31.3%
ALXO shares outstanding is up +31.3% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.96
ALXO beta is 0.96

200-day SMA

$2.13
ALXO price is currently -76.43% below its 200-day simple moving average

50-day SMA

$0.89
ALXO price is currently -43.65% below its 50-day simple moving average

RSI

30.48
ALXO 14-day relative strength index is 30.48

Volume

0.34
ALXO 30-day relative volume is 0.34

ATR

$0.07
ALXO average true range is $0.07

10-day Historical Volatility

75.89%
ALXO 10-day historical volatility is 75.89%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ALXO annual revenue value is unknown

Revenue Analysts estimate

-
ALXO annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ALXO annual revenue 1-year change is unknown

Revenue Sector rank

-
ALXO annual revenue is unknown

EPS

EPS

-$2.58
ALXO annual earnings per share is -$2.58

EPS Analysts estimate

-$1.14
ALXO annual earnings per share is currently +126.91% higher than the consensus analysts' forecast

EPS 1-year change

+31.02%
ALXO annual earnings per share is up +31.02% year-on-year

EPS Sector rank

33.2%
ALXO annual earnings per share is higher than 33.2% of companies in Healthcare sector

Profit

Gross profit

-
ALXO annual gross profit value is unknown

Gross margin

-
ALXO annual gross profit margin value is unknown

Operating profit

-$142.47M
ALXO annual operating income is -$142.47 million

Operating margin

-
ALXO annual operating profit margin value is unknown

Net income

-$134.85M
ALXO annual net profit is -$134.85 million

Net margin

-
ALXO annual net profit margin value is unknown

Expenses

Total expenses

$142.47M
ALXO annual total expenses is $142.47 million

Operating expenses

$142.47M
ALXO annual total operating expenses is $142.47 million

Cost of goods sold

-
ALXO annual cost of goods sold value is unknown

Selling, general & administrative expenses

$26.09M
ALXO annual SGA is $26.09 million

Depreciation and amortization

$872.00K
ALXO annual depreciation & amortization is $872.00 thousand

Interest expense

$1.73M
ALXO annual interest expense is $1.73 million

Income tax

$0.00
ALXO annual income tax is $0.00

EBIT & EBITDA

EBIT

-$133.12M
ALXO annual earnings before interest & taxes is -$133.12 million

EBITDA

-$132.25M
ALXO annual EBITDA is -$132.25 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$147.78M
ALXO annual total assets is $147.78 million

Non current assets

$13.42M
ALXO annual long term assets is $13.42 million

Current assets

$134.35M
ALXO annual total current assets is $134.35 million

Cash and cash equivalents

$17.57M
ALXO annual cash & cash equivalents is $17.57 million

Accounts receivable

-
ALXO annual accounts receivable value is unknown

Inventory

-
ALXO annual inventory value is unknown

Liabilities

Total liabilities

$34.16M
ALXO annual total liabilities is $34.16 million

Long term liabilities

$15.66M
ALXO annual total long term liabilities is $15.66 million

Current liabilities

$18.50M
ALXO annual total current liabilities is $18.50 million

Accounts payable

$4.50M
ALXO annual accounts payable is $4.50 million

Debt

Total debt

$9.90M
ALXO annual total debt is $9.90 million

Total debt 1-year change

+2.75%
ALXO annual total debt is up +2.75% year-on-year

Long term debt

$9.47M
ALXO annual long term debt is $9.47 million

Short term debt

$435.00K
ALXO annual short term debt is $435.00 thousand

Equity & Capital

Shareholders equity

$113.62M
ALXO annual stockholders equity is $113.62 million

Book value

$113.62M
ALXO annual book value is $113.62 million

Retained earnings

-$621.12M
ALXO annual retained earnings is -$621.12 million

Working capital

$115.85M
ALXO annual working capital is $115.85 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$121.91M
ALXO annual cash flow from operations is -$121.91 million

Cash from operations 1-year change

+6.48%
ALXO annual cash flow from operations is up +6.48% year-on-year

Cash from investing

$86.26M
ALXO annual cash flow from investing activities is $86.26 million

Cash from investing 1-year change

+93.15%
ALXO annual cash flow from investing activities is up +93.15% year-on-year

Cash from financing

$30.82M
ALXO annual cash flow from financing activities is $30.82 million

Cash from financing 1-year change

-48.02%
ALXO annual cash flow from financing activities is down -48.02% year-on-year

CAPEX

CAPEX

-
ALXO annual capital expenditures value is unknown

CAPEX 1-year change

-
ALXO annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$122.36M
ALXO annual free cash flow is -$122.36 million

Free cash flow 1-year change

+7.05%
ALXO annual free cash flow is up +7.05% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ALXO annual gross profit margin value is unknown

Operating margin

-
ALXO annual operating profit margin value is unknown

Net margin

-
ALXO annual net profit margin value is unknown

ROA & ROE

ROA

-91.25%
ALXO annual return on assets is -91.25%

ROE

-118.69%
ALXO annual return on equity is -118.69%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ALXO price to earnings ratio value is unknown

PE ratio Sector rank

-
ALXO price to earnings ratio is unknown

PB Ratio

PB ratio

0.24
ALXO price to book ratio is 0.24

PB ratio Sector rank

20.97%
ALXO price to book ratio is higher than 20.97% of companies in Healthcare sector

PS Ratio

PS ratio

-
ALXO price to sales ratio value is unknown

PS ratio Sector rank

-
ALXO price to sales ratio is unknown

Enterprise value

Enterprise value

$19.10M
ALXO enterprise value is $19.10 million

Enterprise value Sector rank

31.79%
ALXO enterprise value is higher than 31.79% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.14
ALXO EV/EBITDA is -0.14

EV/EBITDA Sector rank

59.77%
ALXO EV/EBITDA is higher than 59.77% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

7.26
ALXO annual current ratio is 7.26

Quick ratio

-
ALXO annual quick ratio value is unknown

Leverage

Debt to equity

0.09
ALXO annual debt to equity ratio is 0.09

Interest coverage ratio

-76.99
ALXO annual interest coverage ratio is -76.99

Risk & Stability

Piotroski F-Score

-
ALXO piotroski f-score value is unknown

Altman Z-Score

-
ALXO altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 7, 25 Stifel
Hold
Mar 7, 25 HC Wainwright & Co.
Buy
Mar 6, 25 Piper Sandler
Overweight
Mar 6, 25 Jefferies
Buy
Jan 27, 25 UBS
Buy
Jan 24, 25 HC Wainwright & Co.
Buy
Jan 24, 25 Cantor Fitzgerald
Overweight
Dec 19, 24 Jefferies
Hold
Dec 18, 24 HC Wainwright & Co.
Buy
Dec 18, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

VYNE logo
VYNE Therapeutics (VYNE)
Aspire BioPharma (ASBP)
PLUR logo
Pluri (PLUR)
PYPD logo
PolyPid (PYPD)
AKTX logo
Akari Therapeutics (AKTX)
DARE logo
Dare Bioscience (DARE)
MLEC logo
Moolec Science SA (MLEC)
BOLD logo
Boundless Bio (BOLD)
POCI logo
Precision Optics (POCI)
  • What is the ticker symbol for ALX Oncology Holdings?
  • Does ALX Oncology Holdings pay dividends?
  • What sector is ALX Oncology Holdings in?
  • What industry is ALX Oncology Holdings in?
  • What country is ALX Oncology Holdings based in?
  • When did ALX Oncology Holdings go public?
  • Is ALX Oncology Holdings in the S&P 500?
  • Is ALX Oncology Holdings in the NASDAQ 100?
  • Is ALX Oncology Holdings in the Dow Jones?
  • When was ALX Oncology Holdings's last earnings report?
  • When does ALX Oncology Holdings report earnings?
  • Should I buy ALX Oncology Holdings stock now?

What is the ticker symbol for ALX Oncology Holdings?

The ticker symbol for ALX Oncology Holdings is NASDAQ:ALXO

Does ALX Oncology Holdings pay dividends?

No, ALX Oncology Holdings does not pay dividends

What sector is ALX Oncology Holdings in?

ALX Oncology Holdings is in the Healthcare sector

What industry is ALX Oncology Holdings in?

ALX Oncology Holdings is in the Biotechnology industry

What country is ALX Oncology Holdings based in?

ALX Oncology Holdings is headquartered in United States

When did ALX Oncology Holdings go public?

ALX Oncology Holdings's initial public offering (IPO) was on July 17, 2020

Is ALX Oncology Holdings in the S&P 500?

No, ALX Oncology Holdings is not included in the S&P 500 index

Is ALX Oncology Holdings in the NASDAQ 100?

No, ALX Oncology Holdings is not included in the NASDAQ 100 index

Is ALX Oncology Holdings in the Dow Jones?

No, ALX Oncology Holdings is not included in the Dow Jones index

When was ALX Oncology Holdings's last earnings report?

ALX Oncology Holdings's most recent earnings report was on Mar 6, 2025

When does ALX Oncology Holdings report earnings?

The next expected earnings date for ALX Oncology Holdings is May 9, 2025

Should I buy ALX Oncology Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page